10x Genomics (TXG) Shares Issued (2018 - 2026)

10x Genomics has disclosed Shares Issued across 9 years of filings, most recently posting $273000.0 for Q1 2026.

• Shares Issued for Q1 2026 came in at $273000.0, down 35.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.7 million (down 31.39% YoY), and the FY2025 annual result was $6.8 million, down 37.67% from the prior year.
• Shares Issued came in at $273000.0 for Q1 2026 at 10x Genomics, down from $2.2 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $7.8 million in Q1 2022 to a low of $156000.0 in Q3 2024.
• The 5-year median for Shares Issued is $3.5 million (2025), against an average of $3.5 million.
• Across the five-year window, Shares Issued slumped 96.43% in 2024 and jumped 295.51% in 2025, its largest moves.
• 10x Genomics' Shares Issued stood at $5.0 million in 2022, then climbed by 12.24% to $5.6 million in 2023, then dropped by 19.53% to $4.5 million in 2024, then sank by 50.37% to $2.2 million in 2025, then tumbled by 87.82% to $273000.0 in 2026.
• The last three Shares Issued figures came in at $273000.0 (Q1 2026), $2.2 million (Q4 2025), and $617000.0 (Q3 2025), per Business Quant data.